YIKSIAM MARQUEZ FERNANDEZ: Open Payments
NPI 1548845969 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,041 in 130 payments from 21 companies in 2025. Trend: 2023 $2,194 · 2024 $2,808 · 2025 $3,041
Food & beverage: $2,752Education: $288
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $595 |
| UCB, Inc. | 18 | $386 |
| Regeneron Healthcare Solutions, Inc. | 7 | $274 |
| Galderma Laboratories, L.P. | 10 | $245 |
| GENZYME CORPORATION | 7 | $201 |
| ABBVIE INC. | 9 | $189 |
| E.R. Squibb & Sons, L.L.C. | 8 | $184 |
| Arcutis Biotherapeutics, Inc. | 9 | $151 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| Lilly USA, LLC | 5 | $132 |
Products named: TREMFYA, DUPIXENT, Bimzelx, NEMLUVIO, Sotyktu, SKYRIZI, Zoryve, EBGLYSS.
Industry payments across FL — which companies pay providers there.
